Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,318.40
-1.60 (-0.07%)
Aug 14, 2026, 3:14 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 654.25 billion as of August 14, 2026. Its market cap has increased by 14.25% in one year.
Market Cap
654.25B
Enterprise Value
648.42B
Revenue
177.37B
Ranking
n/a
PE Ratio
36.40
Stock Price
2,318.40
ChartMarket Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 654.25B, an increase of 56,826.17%. That is a compound annual growth rate of 28.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 654.25B | 13.92% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.20T |
| Cipla | 1.18T |
| Mankind Pharma | 1.00T |
| Laurus Labs | 998.73B |
| Aurobindo Pharma | 959.15B |
| Alkem Laboratories | 655.22B |
| Gland Pharma | 476.93B |
| Ipca Laboratories | 448.19B |